Academic Journal

Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study

التفاصيل البيبلوغرافية
العنوان: Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study
المؤلفون: Hayler Raymond, Lockhart Kathleen, Barat Shoma, Cheng Ernest, Mui Jasmine, Shamavonian Raphael, Ahmadi Nima, Alzahrani Nayef, Liauw Winston, Morris David
المصدر: Pleura and Peritoneum, Vol 8, Iss 1, Pp 27-35 (2023)
بيانات النشر: De Gruyter, 2023.
سنة النشر: 2023
المجموعة: LCC:Medicine
LCC:Specialties of internal medicine
مصطلحات موضوعية: cytoreductive surgery, early postoperative intra-peritoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, pseudomyxoma peritonei, survival analysis, Medicine, Specialties of internal medicine, RC581-951
الوصف: Appendiceal cancer is a rare malignancy, occurring in roughly 1.2 per 100,000 per year. Low grade appendiceal neoplasams (LAMN) in particular can lead to pseudomyxoma peritonei (PMP), and respond poorly to systemic chemotherapy. Standard treatment includes cytoreduction surgery (CRS) with addition of heated intraoperative peritoneal chemotherapy (HIPEC). Several centres include early postoperative intraperitoneal chemotherapy (EPIC) however; the literature is mixed on the benefits. We aim to examine the benefits of additional EPIC through a propensity-matched analysis.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2364-768X
Relation: https://doaj.org/toc/2364-768X
DOI: 10.1515/pp-2022-0205
URL الوصول: https://doaj.org/article/3bfb0211487a413aa66ae0376e00c212
رقم الانضمام: edsdoj.3bfb0211487a413aa66ae0376e00c212
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2364768X
DOI:10.1515/pp-2022-0205